Exendin-4(Lys27 PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) mice.
Annie HasibMing T NgNeil TandaySarah L CraigVictor A GaultPeter R FlattNigel IrwinPublished in: Diabetes/metabolism research and reviews (2018)
This study emphasizes the therapeutic promise of long-acting, multi-targeting hybrid gut peptides for type 2 diabetes.